[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@adamfeuerstein Adam Feuerstein ✡️

Adam Feuerstein ✡️ posts on X about $aclx, $srpt, $tern, $kymr the most. They currently have XXXXXXX followers and XX posts still getting attention that total XXXXXX engagements in the last XX hours.

Engagements: XXXXXX #

X Week XXXXXXX -XXXX%
X Month XXXXXXXXX +0.14%
X Months XXXXXXXXX +42%
X Year XXXXXXXXXX +47%

Mentions: XX #

X Week XX -XX%
X Month XXX -XXXX%
X Months XXX +49%
X Year XXXXX +61%

Followers: XXXXXXX #

X Week XXXXXXX +0.12%
X Month XXXXXXX +0.07%
X Months XXXXXXX +3.40%
X Year XXXXXXX +5.30%

CreatorRank: XXXXXXX #

Social Influence

Social category influence stocks #4795 finance XXXX% technology brands XXXX% cryptocurrencies XXXX%

Social topic influence $aclx #3, $srpt #16, $tern #13, $kymr #5, $dyn #3, $fulc #5, cdc #116, protocol 2.33%, $capr 2.33%, $wve #9

Top accounts mentioned or mentioned by @jasonmmast @kinatsofrim @seedy19tron @statnews @fwcweather @mbrushstocks @desertdweller93 @lizzylaw @jonathanwosen @matthewherper @yhdjdhd @bussinbiotech @justiceforb_md @michaelmaiello @decoakley @komatinskys @precisesvj @oshea9_harry @yusufhameed @trinh_pham13

Top Social Posts

Top posts by engagements in the last XX hours

"$SLNO is repurchasing $100M of its stock. Strong move"
X Link 2025-11-11T12:05Z 121.9K followers, 33K engagements

"CDC panel recommends delaying birth dose of hepatitis B vaccine via @statnews"
X Link 2025-12-05T15:44Z 121.9K followers, 6362 engagements

"New data from Gilead Arcellx multiple myeloma CAR-T suggest benefit over rival treatment $GILD $ACLX $JNJ $LEGN #ASH25"
X Link 2025-12-07T16:00Z 121.9K followers, 15.7K engagements

"Pluvicto - proven to benefit prostate cancer patients. Anktiva - no data no proof it does anything at all for proststr cancer patients. @ScottAdamsSays is taking both drugs. Pluvicto is helping him. Anktiva is not"
X Link 2025-12-07T23:35Z 121.9K followers, 36.7K engagements

"Here is Vinay Prasad's memo/email in full laying out the FDA's new vaccine policy. ------ From: Prasad Vinayak Vinayak.Prasad@fda.hhs.gov Sent: Friday November XX 2025 4:21 PM To: CBER-SUBSCRIBERS-ALL CBER-SUBSCRIBERS-ALL@fda.hhs.gov Subject: Deaths in children due to COVID-19 vaccines and CBER's path forward Dear Team CBER I am writing to report that OBPV career staff have found that at least XX children have died after and because of receiving COVID-19 vaccination. These deaths are related to vaccination (likely/probable/possible attribution made by staff). That number is certainly an"
X Link 2025-11-29T21:43Z 121.9K followers, 199.6K engagements

"BREAKING: Top drug regulator Richard Pazdur set to leave FDA via @LizzyLaw_"
X Link 2025-12-02T16:06Z 121.9K followers, 122.9K engagements

"BREAKING: Capricor $CAPR says its cell therapy improved heart and muscle function in Duchenne patients The dual outcomes in a Phase X study will likely bolster the treatments regulatory future via @Jasonmmast and me"
X Link 2025-12-03T12:21Z 121.9K followers, 20.9K engagements

"Part 3: What West Virginia teens lost when CDC cuts ended their fight against Big Tobacco. What am I going to do from here on out one youth activist asks. By Sarah Todd"
X Link 2025-12-04T13:06Z 121.9K followers, 8026 engagements

"Happy Monday morning Should be a busy one with weekend ASH stock trading + $KYMR $DYN $GPCR $WVE data readouts. And of course everyone will be buying more $ABVX"
X Link 2025-12-08T10:51Z 121.9K followers, 12.8K engagements

"$DYN Dyne Therapeutics plans to file for approval for next-generation Duchenne drug. The medicine could be a more effective version of controversial Sarepta $SRPT drug via @Jasonmmast"
X Link 2025-12-08T11:37Z 121.9K followers, 10.3K engagements

"$AGIO FDA decision on mitapvat thalassemia submission delayed"
X Link 2025-12-08T12:04Z 121.9K followers, 14.4K engagements

"$TERN investor dinner tonight in Orlando via Jefferies is standing room only. They ran out of seats and chicken stragglers only get dinner rolls thrown to them"
X Link 2025-12-08T21:43Z 121.9K followers, 16.2K engagements

"Richard Ebright - the pathetic anger-addled charlatan will spend the remainder of his useless life screaming obscenities into the dark void of X. Enjoy your irrelevance Dick"
X Link 2025-12-09T15:18Z 121.9K followers, 26.4K engagements

"This week's Biotech Scorecard newsletter: Richard Pazdur surely has many items on his to-do list now that hes the top drug regulator at the Food and Drug Administration. One of the decisions he will soon help make how to deal with the dangling accelerated approvals given to Sarepta Therapeutics $SRPT for its Duchenne muscular dystrophy drugs will tell us a lot about how much independence and scientific rigor Pazdur intends to bring to the new job"
X Link 2025-11-20T15:03Z 121.9K followers, 12.1K engagements

"Also my gratitude list for 2025"
X Link 2025-11-20T15:03Z 121.9K followers, 5860 engagements

"Wait. I thought biotech stock prices only go up $JANX"
X Link 2025-12-01T22:05Z 121.9K followers, 13.6K engagements

"Like old times. The wall-crossed PIPE is back. Thank you $ORKA Orka raised $180M at $XX (market price) from a galaxy of biotech hedge funds - XX funds listed in the press release alone. All were given an advance peek at the new first-in-human PK data for ORKA-001 Orka's long-acting IL-23 antibody showing an approximate XXX day half life. The company says it supports the potential for once-yearly maintenance dosing in psoriasis. Phase 2a study underway data in 2H '26"
X Link 2025-09-17T10:29Z 121.9K followers, 16.1K engagements

"I wrote this for tomorrows Biotech Scorecard newsletter BEFORE Heg was named Pazdurs replacement. . Some biotech investor friends tell me I worry too much. The sector has performed exceptionally well this year despite the FDA tumult. M&A activity is red hot. Drug launches are robust. Even macro factors like interest rates and drug-pricing threats long a sector headwind are now reversing course. All true for now. But the FDA is being dismantled from the inside. If allowed to continue the repercussions will be dire even for my most optimistic biotech investor friends"
X Link 2025-12-04T00:59Z 121.9K followers, 26K engagements

"What to expect at the #ASH25 meeting and some thoughts on the FDAs Richard Pazdur $TERN $INCY $ACLX $FULC"
X Link 2025-12-04T16:04Z 121.9K followers, 7581 engagements

"$BMY should buy $TERN $BMY needs to buy $TERN If everyone else can make M&A predictions on this site so can I"
X Link 2025-12-08T20:05Z 121.9K followers, 20.2K engagements

"Friends - My humble request is that you sign up for the email version of my weekly newsletter. Its contents are also posted on STAT's website but the email arrives every Thursday at 6:30 am ET which means you can hate-read it over coffee"
X Link 2024-10-24T14:34Z 121.9K followers, 302.8K engagements

"$SRPT New Elevidys label"
X Link 2025-11-14T19:00Z 121.9K followers, 15.8K engagements

"Poll: Will Marty Makary be FDA Commissioner on Monday"
X Link 2025-12-05T21:24Z 121.9K followers, 62K engagements

"$SNDX posted the Revuforj presentation on its web site"
X Link 2025-12-06T18:12Z 121.9K followers, 9719 engagements

"Hello If you can break away from college football for a moment. #ASH25 Day One recap $SNDX Revuforj frontline AML results $VRTX $CRSP Casgevy in young kids Star Therapeutics - Von Willebrand disease Stand up for Science buttons and a brief STAT event recap via @statnews"
X Link 2025-12-06T21:09Z 121.9K followers, 16.2K engagements

"Fulcrum $FULC study suggests improved efficacy for higher dose sickle cell pill via @Jasonmmast #ASH25"
X Link 2025-12-07T17:28Z 121.9K followers, 11.4K engagements

"Kymera $KYMR drug positioned to rival Sanofi and Regenerons Dupixent succeeds in early-stage eczema trial via @JonathanWosen $SNY $REGN"
X Link 2025-12-08T12:01Z 121.9K followers, 12.8K engagements

"$TERN Results in Terns leukemia drug study suggest it could be a successor to Novartis $NVS blockbuster #ASH25"
X Link 2025-12-08T19:46Z 121.9K followers, 14.8K engagements

"$2 billion of stock being offered tonight collectively from $GPCR $DYN $VERA $FULC $WVE $KYMR and it's only 4:06 pm"
X Link 2025-12-08T21:06Z 121.9K followers, 21.7K engagements

"$ABVX raised $700M in July and didnt use JP Morgan. If youre searching for a likely reason ABVX Is not presenting at JPM26 see above"
X Link 2025-12-10T00:41Z 121.9K followers, 75.7K engagements

"@PCM_bio You sound so desperate"
X Link 2025-12-10T01:38Z 121.9K followers, 3101 engagements

"This week's Biotech Scorecard newsletter: The FDA is a mess but don't blame it for everything I write about $QURE and $BHVN Re: Uniqure and its gene therapy for Huntington's disease the dissonance between the FDA's words and actions can be confusing. Approving AMT-130 seems like a no-brainer win for the FDA and the policy initiatives pushed by its leadership. The reversal certainly has Prasad's conservative data-stickler fingerprints all over it BUT. You have to consider the possibility that there is a significant issue with the AMT-130 data the composition of the external control group or"
X Link 2025-11-06T14:27Z 121.8K followers, 28.8K engagements

"FDAs stronger warning on Sarepta $SRPT gene therapy raises new questions about heart risk via @Jasonmmast and me"
X Link 2025-11-18T15:30Z 121.9K followers, 20K engagements

"@TheBiotechBear zilch. Orlando and New Orleans are on the regular ASH meeting rotation just not as frequently as San Diego"
X Link 2025-12-05T19:23Z 121.9K followers, 5192 engagements

"How the first nine drug companies won priority review vouchers from Marty Makarys FDA via @LizzyLaw_ $DISC $RVMD $REGN $ACHV"
X Link 2025-10-24T14:13Z 121.9K followers, 7866 engagements

"$NKTR fans next time"
X Link 2025-10-24T16:35Z 121.9K followers, 17.3K engagements

"$ALKS increases bid for $AVDL to $XXXXX per share topping Lundbeck"
X Link 2025-11-19T11:07Z 121.9K followers, 9234 engagements

"@seedy19tron Seriously @seedy19tron - you spend a week at the Jefferies conference and $PTN is your long idea"
X Link 2025-11-21T19:37Z 121.9K followers, 6381 engagements

"$ACLX sold off on the Kelonia Therapeutics (private) #ASH25 LBA1 in vivo BCMA CAR-T for multiple myeloma"
X Link 2025-11-24T17:50Z 121.9K followers, 30.2K engagements

"@Sanctuary_Bio $ACLX was going to sell off on ASH anyway so maybe it's just happening sooner"
X Link 2025-11-24T18:04Z 121.9K followers, 2526 engagements

"Here is a clip from the Kelonia #ASH XX abstract. FYI. $ACLX Results: Patients (N=3) ranged from age 61-72 and their time from diagnosis was 7.9-9.4 yrs. All had high-risk cytogenetics and 3-4 prior lines of therapy. Two were refractory to a PI an IMiD and anti-CD38 therapy. All were nave to BCMA-targeted therapies; none had extramedullary involvement. Time from consent to infusion was 13-18 days. All patients experienced treatment-emergent adverse events (AEs) primarily around infusion and during CAR-T expansion. Two patients developed infusion-related reaction (IRR) 30-60 min post-infusion"
X Link 2025-11-24T18:10Z 121.9K followers, 17.6K engagements

"$NTLA update on FDA clinical hold should be imminent if not overdue already"
X Link 2025-12-01T21:49Z 121.9K followers, 16.1K engagements

"On $CAPR the primary endpoint was not changed. Those alleging otherwise are incorrect. The mean change on the PUL XXX endpoint was XXX points favoring deramiocel over placebo. From CEO Linda Marban: "Capricors external statistical vendor followed the pre-specified statistical analysis for the protocol specified primary endpoint of the HOPE-3 trial. This was detailed in a statistical analysis plan that was finalized prior to unblinding.""
X Link 2025-12-03T13:00Z 121.9K followers, 65.2K engagements

"Tracy Beth Heg Makary aide who investigated Covid vaccines to lead FDA drug center via @statnews"
X Link 2025-12-04T00:33Z 121.9K followers, 19.1K engagements

"@InvestorsLive $SLS too small insignificant for me to write about now. But if youre interested todays PR is data-mined"
X Link 2018-04-02T15:16Z 121.9K followers, XX engagements